Gene · 406921
Papers4,561
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 4,561
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Extracellular vesicles as bioactive nanotherapeutics: An emerging paradigm for regenerative medicine. | Theranostics | 2022 | 35836815 | PubTator, text mining | PubMed |
| Recent Progress in Development of Dressings Used for Diabetic Wounds with Special Emphasis on Scaffolds. | Biomed Res Int | 2022 | 35832856 | PubTator, text mining | PubMed |
| The involvement of microRNAs in HCV and HIV infection. | Ther Adv Vaccines Immunother | 2022 | 35832725 | PubTator, text mining | PubMed |
| MicroRNAs as biomarkers for monitoring cardiovascular changes in Type II Diabetes Mellitus (T2DM) and exercise. | J Diabetes Metab Disord | 2022 | 35818628 | PubTator, text mining | PubMed |
| Exosomal circWDR62 promotes temozolomide resistance and malignant progression through regulation of the miR-370-3p/MGMT axis in glioma. | Cell Death Dis | 2022 | 35817771 | PubTator, text mining | PubMed |
| Specific miRNAs Change After 3 Months of GH treatment and Contribute to Explain the Growth Response After 12 Months. | Front Endocrinol (Lausanne) | 2022 | 35813630 | PubTator, text mining | PubMed |
| The trichloroethylene metabolite S-(1,2-dichlorovinyl)-l-cysteine inhibits lipopolysaccharide-induced inflammation transcriptomic pathways and cytokine secretion in a macrophage cell model. | Toxicol In Vitro | 2022 | 35811015 | PubTator, text mining | PubMed |
| MicroRNA Methylome Signature and Their Functional Roles in Colorectal Cancer Diagnosis, Prognosis, and Chemoresistance. | Int J Mol Sci | 2022 | 35806286 | PubTator, text mining | PubMed |
| Different Sourced Extracellular Vesicles and Their Potential Applications in Clinical Treatments. | Cells | 2022 | 35805074 | PubTator, text mining | PubMed |
| The Role of microRNAs in Multidrug Resistance of Glioblastoma. | Cancers (Basel) | 2022 | 35804989 | PubTator, text mining | PubMed |
| The New Face of a Well-Known Antibiotic: A Review of the Anticancer Activity of Enoxacin and Its Derivatives. | Cancers (Basel) | 2022 | 35804828 | PubTator, text mining | PubMed |
| Differential expression profile of plasma exosomal microRNAs in acute type A aortic dissection with acute lung injury. | Sci Rep | 2022 | 35804020 | PubTator, text mining | PubMed |
| Fusobacterium nucleatum: a new player in regulation of cancer development and therapeutic response. | Cancer Drug Resist | 2022 | 35800370 | PubTator, text mining | PubMed |
| Identification of Potential miRNA-mRNA Regulatory Network in Denervated Muscular Atrophy by Bioinformatic Analysis. | Biomed Res Int | 2022 | 35800215 | PubTator, text mining | PubMed |
| Adipocyte differentiation between obese and lean conditions depends on changes in miRNA expression. | Sci Rep | 2022 | 35798800 | PubTator, text mining | PubMed |
| Long Intergenic Noncoding RNAs Affect Biological Pathways Underlying Autoimmune and Neurodegenerative Disorders. | Mol Neurobiol | 2022 | 35796900 | PubTator, text mining | PubMed |
| MicroRNA-34a: A Novel Therapeutic Target in Fibrosis. | Front Physiol | 2022 | 35795649 | PubTator, text mining | PubMed |
| MicroRNA-34a and microRNA-146a target CELF3 and suppress the osteogenic differentiation of periodontal ligament stem cells under cyclic mechanical stretch. | J Dent Sci | 2022 | 35784124 | PubTator, text mining | PubMed |
| Plasma Exosome miRNAs Profile in Patients With ST-Segment Elevation Myocardial Infarction. | Front Cardiovasc Med | 2022 | 35783838 | PubTator, text mining | PubMed |
| Pathogenic role of microRNAs in atherosclerotic ischemic stroke: Implications for diagnosis and therapy. | Genes Dis | 2022 | 35782982 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406921/papers?page=47